1
Clinical Trials associated with Donor-Alloantigen-Reactive Regulatory T Cell Infusion(Rho Federal Systems Division)Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Liver Transplantation (RTB-002)
The purpose of this study is look at the safety of:
Taking a specific combination of immunosuppressant drugs after liver transplantation
Receiving one of three different doses of donor-alloantigen-reactive regulatory T cells (darTregs) while taking this specific combination of drugs
100 Clinical Results associated with Donor-Alloantigen-Reactive Regulatory T Cell Infusion(Rho Federal Systems Division)
100 Translational Medicine associated with Donor-Alloantigen-Reactive Regulatory T Cell Infusion(Rho Federal Systems Division)
100 Patents (Medical) associated with Donor-Alloantigen-Reactive Regulatory T Cell Infusion(Rho Federal Systems Division)
100 Deals associated with Donor-Alloantigen-Reactive Regulatory T Cell Infusion(Rho Federal Systems Division)